Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Globalspace Technologies Ltd, a small-cap listed SaaS and digital solutions company focused on healthcare and pharma, has announced the launch of PATGPT, a pharma-specific Large Language Model (LLM) platform. The product uses a hybrid model — 50% is pre-trained by Globalspace on pharmaceutical datasets, while the remaining 50% is customized using each client's own proprietary data within their secure cloud. In the first phase, PATGPT will target sales, marketing, inventory, and distribution optimization for pharma companies. Future plans include expanding into R&D, clinical trials, pharmacovigilance, and regulatory submissions. The company sees this as opening new revenue streams through both product licensing and AI training services.
The launch signals Globalspace's move into the high-growth AI-for-pharma space and could open new revenue streams beyond its existing SaaS business. However, since the company is small-cap and the product is newly launched with no revenue or client numbers disclosed, retail investors should watch for follow-up announcements on customer wins, order book, and financial impact before drawing strong conclusions.